A company is performing routine site monitoring of its pivotal clinical study for a
... [Show More]
blood sugar meter and finds one site has not consented 1/3 of its subjects properly. What is the FIRST thing the company needs to do? A. Stop the entire study B. Inform FDA and ask for guidance C. Re-train the study staff, including the principle investigator
[Show Less]